BIOMAT Database Logo BIOMAT Database Logo

Single amino acid substitutions dissociate fibrinogen-clotting and thrombomodulin-binding activities of human thrombin. 1991

Q Y Wu, and J P Sheehan, and M Tsiang, and S R Lentz, and J J Birktoft, and J E Sadler
Howard Hughes Medical Institute, Department of Medicine, Jewish Hospital of St. Louis, Washington University School of Medicine, MO 63110.

Thrombin is a serine protease that acts as a procoagulant by clotting fibrinogen and activating platelets and as an anticoagulant by activating protein C in a thrombomodulin-dependent reaction. Fibrinogen and thrombomodulin bind competitively to an anion-binding exosite on thrombin. We prepared recombinant normal human thrombin and mutant thrombins with single amino acid substitutions in order to localize and distinguish the fibrinogen- and thrombomodulin-binding sites. Normal and mutant thrombins had similar amidolytic activity. Thrombin K52E had approximately 2.5-fold increased protein C-activating activity but only approximately 17% of normal fibrinogen-clotting activity. Thrombin R70E had normal fibrinogen-clotting activity but only approximately 7% of normal protein C-activating activity. Thrombin R68E had markedly reduced activity in both assays. Decreased activation of protein C correlated with decreased binding affinity for thrombomodulin, and ability to activate platelets correlated directly with fibrinogen-clotting activity. These results demonstrate that thrombins with predominantly anticoagulant or procoagulant activity can be created by mutagenesis and that thrombomodulin- and fibrinogen-binding sites on thrombin may overlap but are not identical.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D010974 Platelet Aggregation The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS. Aggregation, Platelet
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D011516 Prothrombin A plasma protein that is the inactive precursor of thrombin. It is converted to thrombin by a prothrombin activator complex consisting of factor Xa, factor V, phospholipid, and calcium ions. Deficiency of prothrombin leads to hypoprothrombinemia. Coagulation Factor II,Factor II,Blood Coagulation Factor II,Differentiation Reversal Factor,Factor II, Coagulation,Factor, Differentiation Reversal,II, Coagulation Factor
D011956 Receptors, Cell Surface Cell surface proteins that bind signalling molecules external to the cell with high affinity and convert this extracellular event into one or more intracellular signals that alter the behavior of the target cell (From Alberts, Molecular Biology of the Cell, 2nd ed, pp693-5). Cell surface receptors, unlike enzymes, do not chemically alter their ligands. Cell Surface Receptor,Cell Surface Receptors,Hormone Receptors, Cell Surface,Receptors, Endogenous Substances,Cell Surface Hormone Receptors,Endogenous Substances Receptors,Receptor, Cell Surface,Surface Receptor, Cell
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003198 Computer Simulation Computer-based representation of physical systems and phenomena such as chemical processes. Computational Modeling,Computational Modelling,Computer Models,In silico Modeling,In silico Models,In silico Simulation,Models, Computer,Computerized Models,Computer Model,Computer Simulations,Computerized Model,In silico Model,Model, Computer,Model, Computerized,Model, In silico,Modeling, Computational,Modeling, In silico,Modelling, Computational,Simulation, Computer,Simulation, In silico,Simulations, Computer
D005340 Fibrinogen Plasma glycoprotein clotted by thrombin, composed of a dimer of three non-identical pairs of polypeptide chains (alpha, beta, gamma) held together by disulfide bonds. Fibrinogen clotting is a sol-gel change involving complex molecular arrangements: whereas fibrinogen is cleaved by thrombin to form polypeptides A and B, the proteolytic action of other enzymes yields different fibrinogen degradation products. Coagulation Factor I,Factor I,Blood Coagulation Factor I,gamma-Fibrinogen,Factor I, Coagulation,gamma Fibrinogen

Related Publications

Q Y Wu, and J P Sheehan, and M Tsiang, and S R Lentz, and J J Birktoft, and J E Sadler
Single amino acid substitutions uncouple the DNA binding and strand scission activities of Fok I endonuclease.
October 1993, Proceedings of the National Academy of Sciences of the United States of America,
Q Y Wu, and J P Sheehan, and M Tsiang, and S R Lentz, and J J Birktoft, and J E Sadler
Action of poly-alpha-amino acids on clotting of fibrinogen by thrombin.
October 1954, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
Q Y Wu, and J P Sheehan, and M Tsiang, and S R Lentz, and J J Birktoft, and J E Sadler
Equilibrium binding of thrombin to recombinant human thrombomodulin: effect of hirudin, fibrinogen, factor Va, and peptide analogues.
November 1990, Biochemistry,
Q Y Wu, and J P Sheehan, and M Tsiang, and S R Lentz, and J J Birktoft, and J E Sadler
Localization of thrombomodulin-binding site within human thrombin.
August 1990, The Journal of biological chemistry,
Q Y Wu, and J P Sheehan, and M Tsiang, and S R Lentz, and J J Birktoft, and J E Sadler
Modification of human thrombin: effect on thrombomodulin binding.
June 1988, Thrombosis and haemostasis,
Q Y Wu, and J P Sheehan, and M Tsiang, and S R Lentz, and J J Birktoft, and J E Sadler
Thrombin specificity with tripeptide chromogenic substrates: comparison of human and bovine thrombins with and without fibrinogen clotting activities.
June 1986, Clinical chemistry,
Q Y Wu, and J P Sheehan, and M Tsiang, and S R Lentz, and J J Birktoft, and J E Sadler
Single amino acid substitutions in influenza haemagglutinin change receptor binding specificity.
January 1983, Nature,
Q Y Wu, and J P Sheehan, and M Tsiang, and S R Lentz, and J J Birktoft, and J E Sadler
Thrombin - fibrinogen clotting times. Instability and assay variance.
December 1968, Thrombosis et diathesis haemorrhagica,
Q Y Wu, and J P Sheehan, and M Tsiang, and S R Lentz, and J J Birktoft, and J E Sadler
Macromolecular specificity determinants on thrombin for fibrinogen and thrombomodulin.
July 1989, The Journal of biological chemistry,
Q Y Wu, and J P Sheehan, and M Tsiang, and S R Lentz, and J J Birktoft, and J E Sadler
Action of thrombin in the clotting of fibrinogen.
February 1951, Nature,
Copied contents to your clipboard!